Means and method for the treatment of coronary artery...

Details Means and method for the treatment of coronary artery... Means and method for the treatment of coronary artery...

A - Human Necessities

61

B

A61B 17/00 (2006.01) A61F 2/06 (2006.01) A61L 31/10 (2006.01) A61L 31/16 (2006.01) A61M 25/10 (2006.01)

Patent

CA 2405934

A preferred embodiment of this invention is a stent that is coated with an anti-restenosis drug that is selected from the group that includes, Alkeran, Cytoxan, Leukeran, Cis-platinum, BiCNU, Adriamycin, Doxorubicin, Cerubidine, Idamycin, Mithracin, Mutamycin, Fluorouracil, Methotrexate, Thoguanine, Toxotere, Etoposide, Vincristine, Irinotecan, Hycamptin, Matulane, Vumon, Hexalin, Hydroxyurea, Gemzar, Oncovin, Etophophos, tacrolimus (FK506), and the following analogs of sirolimus: SDZ-RAD, CCI- 779, 7-epi-rapamycin, 7-thiomethyl-rapamycin, 7-epi-trimethoxyphenyl- rapamycin, 7-epi-thiomethyl-rapamycin, 7-demethoxy-rapamycin, 32- demethoxy, 2-desmethyl and proline.

Affiliated with

Also associated with

Rating

Means and method for the treatment of coronary artery... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Means and method for the treatment of coronary artery..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means and method for the treatment of coronary artery... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1917321